Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Lam Research
LRCX
|
+$792M |
| 2 |
Johnson & Johnson
JNJ
|
+$659M |
| 3 |
Datadog
DDOG
|
+$571M |
| 4 |
Amazon
AMZN
|
+$474M |
| 5 |
Broadcom
AVGO
|
+$458M |
Top Sells
| 1 |
Workday
WDAY
|
+$1.23B |
| 2 |
AbbVie
ABBV
|
+$1.03B |
| 3 |
Advanced Micro Devices
AMD
|
+$686M |
| 4 |
Honeywell
HON
|
+$673M |
| 5 |
Amgen
AMGN
|
+$620M |
Sector Composition
| 1 | Technology | 34.72% |
| 2 | Healthcare | 17.58% |
| 3 | Consumer Discretionary | 10.69% |
| 4 | Financials | 10.22% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORKA
626
Oruka Therapeutics, Inc. Common Stock
ORKA
$601M
| $16.4M | 0.01% |
849,410
+613,294
| +260% | +$11.9M |
|
627
Asure Software
ASUR
$222M
| $16.1M | 0.01% |
1,711,437
-31,450
| -2% | -$296K |
|
628
Royal Bank of Canada
RY
$203B
| $16.1M | 0.01% |
133,480
-15,100
| -10% | -$1.82M |
|
629
Air Products & Chemicals
APD
$63.9B
| $16.1M | 0.01% |
55,328
-57,183
| -51% | -$16.6M |
|
630
Business First Bancshares
BFST
$729M
| $16M | 0.01% |
623,464
+328,189
| +111% | +$8.43M |
|
|
WAY
631
Waystar Holding Corp
WAY
$7.12B
| $16M | 0.01% |
+436,190
| New | +$16M |
|
632
California Resources
CRC
$4.27B
| $16M | 0.01% |
308,459
+24,154
| +8% | +$1.25M |
|
633
Burford Capital
BUR
$2.74B
| $16M | 0.01% |
1,232,077
-54,168
| -4% | -$702K |
|
634
Insight Enterprises
NSIT
$3.99B
| $15.9M | 0.01% |
104,809
-84,609
| -45% | -$12.9M |
|
635
Deckers Outdoor
DECK
$17.1B
| $15.9M | 0.01% |
78,296
+43,918
| +128% | +$8.93M |
|
636
nCino
NCNO
$3.52B
| $15.9M | 0.01% |
473,659
+4,418
| +0.9% | +$148K |
|
637
NextEra Energy, Inc.
NEE
$144B
| $15.6M | 0.01% |
217,035
-44,749
| -17% | -$3.21M |
|
638
Fair Isaac
FICO
$37.1B
| $15.6M | 0.01% |
7,821
+3,501
| +81% | +$6.97M |
|
639
Box
BOX
$4.86B
| $15.4M | 0.01% |
487,387
+271,745
| +126% | +$8.59M |
|
640
AT&T
T
$210B
| $15.3M | 0.01% |
671,830
-29,224
| -4% | -$666K |
|
641
CorVel
CRVL
$4.49B
| $15.2M | 0.01% |
136,908
+12,519
| +10% | +$1.39M |
|
642
Kymera Therapeutics
KYMR
$3.11B
| $15.2M | 0.01% |
377,384
+362,276
| +2,398% | +$14.6M |
|
643
Corcept Therapeutics
CORT
$7.56B
| $15.2M | 0.01% |
301,490
-22,527
| -7% | -$1.14M |
|
644
Globant
GLOB
$2.64B
| $15.1M | 0.01% |
70,628
+30,042
| +74% | +$6.44M |
|
645
Simulations Plus
SLP
$285M
| $15.1M | 0.01% |
542,899
+535,986
| +7,753% | +$14.9M |
|
|
BCAX
646
Bicara Therapeutics Inc. Common Stock
BCAX
$680M
| $15M | 0.01% |
863,846
-324,345
| -27% | -$5.64M |
|
|
JMID
647
Janus Henderson Mid Cap Growth Alpha ETF
JMID
$27M
| $15M | 0.01% |
540,153
+340,153
| +170% | +$9.45M |
|
648
Palomar
PLMR
$3.24B
| $14.8M | 0.01% |
140,384
+95,359
| +212% | +$10.1M |
|
649
Brookfield
BN
$99B
| $14.8M | 0.01% |
257,784
-15,772
| -6% | -$906K |
|
650
Carnival PLC
CUK
$37.9B
| $14.8M | 0.01% |
656,770
-31,376
| -5% | -$707K |
|